Home > Publications database > Dynamically chiral phosphonic acid-type metallo-β-lactamase inhibitors |
Journal Article | PUBDB-2025-01464 |
; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ;
2025
Macmillan Publishers Limited, part of Springer Nature
[London]
This record in other databases:
Please use a persistent id in citations: doi:10.1038/s42004-025-01510-5 doi:10.3204/PUBDB-2025-01464
Abstract: Antibiotic resistance is a growing global health threat that risks the lives of millions. Among the resistance mechanisms, that mediated by metallo-β-lactamases is of particular concern as these bacterial enzymes dismantle most β-lactam antibiotics, which are our widest applied and cheapest to produce antibiotic agents. So far, no clinically applicable metallo-β-lactamase inhibitors are available. Aiming to adapt to structural variations, we introduce the inhibitor concept: dynamically chiral phosphonic acids. We demonstrate that they are straightforward to synthesize, penetrate bacterial membranes, inhibit the metallo-β-lactamase enzymes NDM-1, VIM-2 and GIM-1, and are non-toxic to human cells. Mimicking the transition state of β-lactam hydrolysis, they target the Zn ions of the metallo-β-lactamase active site. As a unique feature, both of their stereoisomers bind metallo-β-lactamases, which provides them unparalleled adaptability to the structural diversity of these enzymes, and may allow them to hamper bacteria’s ability for resistance development.
![]() |
The record appears in these collections: |